337 related articles for article (PubMed ID: 34006386)
1. Non-cell-autonomous pathogenic mechanisms in amyotrophic lateral sclerosis.
Van Harten ACM; Phatnani H; Przedborski S
Trends Neurosci; 2021 Aug; 44(8):658-668. PubMed ID: 34006386
[TBL] [Abstract][Full Text] [Related]
2. Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications.
Liu J; Wang F
Front Immunol; 2017; 8():1005. PubMed ID: 28871262
[TBL] [Abstract][Full Text] [Related]
3. Regulation of cortical hyperexcitability in amyotrophic lateral sclerosis: focusing on glial mechanisms.
Xie M; Pallegar PN; Parusel S; Nguyen AT; Wu LJ
Mol Neurodegener; 2023 Oct; 18(1):75. PubMed ID: 37858176
[TBL] [Abstract][Full Text] [Related]
4. Targeting mitochondrial Ca
Zhong R; Rua MT; Wei-LaPierre L
J Physiol; 2024 Apr; 602(8):1519-1549. PubMed ID: 38010626
[TBL] [Abstract][Full Text] [Related]
5. Astrocytes and Microglia as Non-cell Autonomous Players in the Pathogenesis of ALS.
Lee J; Hyeon SJ; Im H; Ryu H; Kim Y; Ryu H
Exp Neurobiol; 2016 Oct; 25(5):233-240. PubMed ID: 27790057
[TBL] [Abstract][Full Text] [Related]
6. The Key Role of Astrocytes in Amyotrophic Lateral Sclerosis and Their Commitment to Glutamate Excitotoxicity.
Provenzano F; Torazza C; Bonifacino T; Bonanno G; Milanese M
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895110
[TBL] [Abstract][Full Text] [Related]
7. The role of glial cells in amyotrophic lateral sclerosis.
Pandya VA; Patani R
Int Rev Neurobiol; 2024; 176():381-450. PubMed ID: 38802179
[TBL] [Abstract][Full Text] [Related]
8. High content analysis in amyotrophic lateral sclerosis.
Rinaldi F; Motti D; Ferraiuolo L; Kaspar BK
Mol Cell Neurosci; 2017 Apr; 80():180-191. PubMed ID: 27965018
[TBL] [Abstract][Full Text] [Related]
9. Neuroinflammation in amyotrophic lateral sclerosis: pathogenic insights and therapeutic implications.
Calma AD; Pavey N; Menon P; Vucic OS
Curr Opin Neurol; 2024 May; ():. PubMed ID: 38775138
[TBL] [Abstract][Full Text] [Related]
10. Amyotrophic lateral sclerosis.
Younger DS; Brown RH
Handb Clin Neurol; 2023; 196():203-229. PubMed ID: 37620070
[TBL] [Abstract][Full Text] [Related]
11. SRF deletion results in earlier disease onset in a mouse model of amyotrophic lateral sclerosis.
Song J; Dikwella N; Sinske D; Roselli F; Knöll B
JCI Insight; 2023 Aug; 8(15):. PubMed ID: 37339001
[TBL] [Abstract][Full Text] [Related]
12. Novel therapeutic approaches for motor neuron disease.
Muzio L; Ghirelli A; Agosta F; Martino G
Handb Clin Neurol; 2023; 196():523-537. PubMed ID: 37620088
[TBL] [Abstract][Full Text] [Related]
13. Astrocytes in amyotrophic lateral sclerosis: direct effects on motor neuron survival.
Staats KA; Van Den Bosch L
J Biol Phys; 2009 Oct; 35(4):337-46. PubMed ID: 19669429
[TBL] [Abstract][Full Text] [Related]
14. Human iPSC co-culture model to investigate the interaction between microglia and motor neurons.
Vahsen BF; Gray E; Candalija A; Cramb KML; Scaber J; Dafinca R; Katsikoudi A; Xu Y; Farrimond L; Wade-Martins R; James WS; Turner MR; Cowley SA; Talbot K
Sci Rep; 2022 Jul; 12(1):12606. PubMed ID: 35871163
[TBL] [Abstract][Full Text] [Related]
15. Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact.
De Marchi F; Munitic I; Amedei A; Berry JD; Feldman EL; Aronica E; Nardo G; Van Weehaeghe D; Niccolai E; Prtenjaca N; Sakowski SA; Bendotti C; Mazzini L
Neurosci Biobehav Rev; 2021 Aug; 127():958-978. PubMed ID: 34153344
[TBL] [Abstract][Full Text] [Related]
16. Amyotrophic Lateral Sclerosis Mechanism: Insights from the
Chen L; Zhang S; Liu S; Gao S
Cells; 2024 Jan; 13(1):. PubMed ID: 38201303
[TBL] [Abstract][Full Text] [Related]
17. The Skeletal Muscle Emerges as a New Disease Target in Amyotrophic Lateral Sclerosis.
Pikatza-Menoio O; Elicegui A; Bengoetxea X; Naldaiz-Gastesi N; López de Munain A; Gerenu G; Gil-Bea FJ; Alonso-Martín S
J Pers Med; 2021 Jul; 11(7):. PubMed ID: 34357138
[TBL] [Abstract][Full Text] [Related]
18. Microglia and Astrocytes in Amyotrophic Lateral Sclerosis: Disease-Associated States, Pathological Roles, and Therapeutic Potential.
You J; Youssef MMM; Santos JR; Lee J; Park J
Biology (Basel); 2023 Oct; 12(10):. PubMed ID: 37887017
[TBL] [Abstract][Full Text] [Related]
19. Immunological drivers of amyotrophic lateral sclerosis.
Gendron TF; Petrucelli L
Sci Transl Med; 2023 Nov; 15(721):eadj9332. PubMed ID: 37939160
[TBL] [Abstract][Full Text] [Related]
20. Nutraceuticals and phytotherapeutics for holistic management of amyotrophic lateral sclerosis.
Katiyar D; Singhal S; Bansal P; Nagarajan K; Grover P
3 Biotech; 2023 Feb; 13(2):62. PubMed ID: 36714551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
